G2B BioSolutions Denmark ApS — Credit Rating and Financial Key Figures
CVR number: 43237748
Hagens Alle 7, 2900 Hellerup
Income statement (kDKK)
2023 | 2024 | |
---|---|---|
Fiscal period length | 12 | 12 |
Net sales | ||
Gross profit | -5.00 | -9.31 |
EBIT | -5.00 | -9.31 |
Other financial expenses | -5.10 | -0.25 |
Pre-tax profit | -10.10 | -9.56 |
Net earnings | -10.10 | -9.56 |
Assets (kDKK)
2022 | 2023 | 2024 | |
---|---|---|---|
Intangible assets total | |||
Tangible assets total | |||
Investments total | |||
Long term receivables total | |||
Inventories total | |||
Current amounts owed by group member comp. | 40.00 | ||
Short term receivables total | 40.00 | ||
Cash and bank deposits | 34.90 | 20.34 | |
Cash and cash equivalents | 34.90 | 20.34 | |
Balance sheet total (assets) | 40.00 | 34.90 | 20.34 |
Equity and liabilities (kDKK)
2022 | 2023 | 2024 | |
---|---|---|---|
Share capital | 40.00 | 40.00 | 40.00 |
Retained earnings | -10.10 | ||
Profit of the financial year | -10.10 | -9.56 | |
Shareholders equity total | 40.00 | 29.90 | 20.34 |
Non-current liabilities total | |||
Short-term deferred tax liabilities | 5.00 | ||
Current liabilities total | 5.00 | ||
Balance sheet total (liabilities) | 40.00 | 34.90 | 20.34 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.